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Salivary nicotine and salivary cotinine is widely used in clinical and epidemiological studies to validate 
smoking cessation. However, the reported collection for salivary nicotine and salivary cotinine vary by 
technique and duration. This study investigated the influence of salivary collection by unstimulation 
and stimulation technique of the concentration of salivary nicotine and salivary cotinine. It was found 
that unstimulated technique produced the highest salivary nicotine concentration, whereas stimulated 
technique produced the highest salivary cotinine concentration. The results of this study suggest that it 
is important to standardise salivary nicotine and cotinine collection technique. 
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INTRODUCTION 
 
Determining the concentration of nicotine and cotinine in 
biological fluids is widely practiced in both epidemio-
logical and clinical smoking studies (Hatsukami et al., 
2003). Both nicotine and cotinine concentrations are used 
to estimate tobacco consumption, to determine exposure 
to environmental smoke and to validate abstinence in 
smoking cessation programmes (Hatsukami et al., 2003; 
Schneider et al., 1997). Nicotine, when smoked in ciga-
rettes is absorbed across buccal and nasal membranes. 
The drug has a fast onset of action with a half-life of 2 h 
and can be detected in blood, saliva and urine 
(Hatsukami et al., 2003). As nicotine is a weak base (pKa 
of 8.0), it is present mainly in the non-ionised form in 
alkaline pH, and hence more easily absorbed with 
increased pH levels (Ciolino et al., 2001a). Thus, 
changes in salivary pH will affect the amount of nicotine 
that is absorbed across the buccal mucosa (Zevin et al., 
1998).Cotinine, the major metabolite of nicotine, is widely 
used for estimating exposure to nicotine. This pharma-
cologically inactive compound has a half-life of 20 h (15 - 
40 h), is slowly cleared from the body  and  is  specific  to 
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tobacco (Hatsukami et al., 2003; Patterson et al., 2003). 
Cotinine has been reported to have a pKa<5.0, and can 
also be detected in urine, blood and saliva (Beckett et al., 
1972; Benowitz, 1996). Urinary levels of cotinine have 
been shown to be quite variable, due to the difference in 
nicotine metabolism among individuals (Yang et al., 
2001). Blood provides quantitative results that can be 
more accurately related to dosing. However, collection of 
blood samples is more invasive. In many nicotine treat-
ment trials, saliva collection is favoured over blood and 
urinary measures as it is easy to obtain and non-invasive 
(Hatsukami et al., 2003). Saliva samples are useful for 
determining compliance with medication (especially in 
paediatric patients), for analysing the concentration of 
free drugs and in situations where repeated sampling is 
necessary. 
Salivary nicotine and cotinine concentration is reported 
to be dependent upon a number of factors. One of the 
factors where variability reportedly arises in salivary nico-
tine and cotinine concentrations is the difference in sam-
ple collection methods (Curvall et al., 1990; Schneider et 
al., 1997). There have been a number of techniques used 
to collect saliva. Saliva can be collected under unstimu-
lated (resting) or stimulated conditions. Among the 
reported disadvantages of collecting unstimulated saliva 
was  insufficient  volume.  Most  studies  have   employed 
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sampling devices that aim to stimulate the production of 
saliva. Among the stimulated techniques, the method of 
stimulation has varied between using wax, sugar, lemon 
juice or other acidic drinks (Curvall et al., 1990; Jarvis et 
al., 2003; Torano and van Kan, 2003; Zevin et al., 2000). 
The use of stimulated saliva has an advantage over 
unstimulated saliva as a larger volume sample could be 
obtained in a short period of time. The importance of 
standardising saliva collection has been highlighted for 
research and clinical practice (Curvall et al., 1990; Di 
Giusto and Eckhard, 1986; Schneider et al., 1997). 
Schneider et al., (1997) reported lowered salivary 
cotinine concentration when the saliva collection was sti-
mulated with wax or sugar compared to when saliva was 
collected without stimulation. No difference in salivary 
cotinine concentration was observed with consecutive 
unstimulated saliva sampling within the same subject. 
However, other earlier studies were less clear cut and 
found no difference in salivary cotinine levels whether the 
sample was collected stimulated or without stimulation 
(Curvall et al., 1990). This study aimed to determine the 
influence of stimulated saliva collection (compared to 
unstimulated collection) on salivary nicotine and cotinine 
concentrations. 
 
 
METHOD 
 
Subjects 
 
Twelve subjects were recruited by on-site poster advertisement. 
The participants were current cigarette smokers (defined as 
someone who had smoked >100 cigarettes in their lifetime and who 
at the time of the study reported that they were smoking) (U.S. 
Department of Health and Human Services 1996). Ethical approval 
was obtained from the South London and Maudsley NHS Trust and 
Institute of Psychiatry Joint Research Committee (Ref 110/03). 
Subjects were asked to complete a self-administered questionnaire 
concerning the number and type of cigarettes smoked per day 
(cig/day) and their smoking pattern in a day. Their height and 
weight measurements were also taken to calculate their body mass 
index (BMI). 
 
 
Procedure 
 
The subjects were asked to come for the study after an overnight 
smoking abstinence (9 h). An overnight smoking abstinence of 9 h 
was required as a wash out period from the previous day smoking 
(half-life nicotine = 2 h). Thus the nicotine measured in the study 
was an estimation of the cigarette smoked at the time of the study. 
The time for saliva collection was also standardised at 9 am in the 
morning. This was because the properties of saliva were not 
constant and varied within an individual (as high as 50%) in a day 
(Dawes, 2005a; Dawes and Kubieniec, 2004). For instance, the 
viscosity of unstimulated saliva was highest in the morning and 
lowest at 5 pm. (Rantonen and Meurman, 1998).  
This variation in the properties of saliva throughout the day may 
have potential impact on salivary drug concentrations. This study 
thus standardised the time of saliva collection to eliminate the 
potential impact of time of day on salivary drug concentration. Prior 
to sample collection, they were asked to rinse out their mouths. An 
unstimulated saliva sample was collected by asking the subjects to 
place a neutral Salivette,  (Sarstedt;  Numbrecht,  Germany)  cotton 
 
 
 
 
wool roll in the mouth (between the gum and cheek) for 2 min, 
within 5 min after smoking a cigarette. This was followed imme-
diately by a stimulated saliva sample, where the subjects were 
asked to chew a second neutral Salivette cotton roll for 2 min.  
The order of testing was not expected to affect nicotine and 
cotinine levels because the combined collection time was less than 
10 min (2 min for unstimulated and 2 min for stimulated). This is 
within the half-life of nicotine, which is approximately 2 h, and the 
half-life of cotinine, 20 h (Hatsukami et al., 2003). Therefore, there 
should not be a significant change in both nicotine and cotinine 
levels within this time frame by either collection method. The saliva 
samples were collected in Salivettes, labelled, centrifuged, 
immediately frozen and couriered in dry ice to the Department of 
Molecular Pharmacology and Pharmacogenetics, Division of 
Clinical Sciences, University of Sheffield for analysis by LCMS 
(Liquid Chromatography Mass Spectrometry). Statistical analysis 
was carried out by SPSS using Paired t-test for dependent 
samples. 
 
 
RESULTS 
 
Subject characteristics 
 
Twelve healthy volunteers (9 males) were recruited for 
this study. Subject characteristics can be found in Table 
1. The volunteers were current smokers, mean age 34.7 
± 10.2 years (range 22 - 54). Six of the subjects smoked 
filtered cigarettes and 6 subjects smoked hand - rolled 
cigarettes. The mean number of cigarettes smoked per 
day (cig/day) was 13.3 ± 5.3 (range 2 - 20) and the mean 
BMI was 25.7 ± 5.1 (range 19.9 - 39.7).One subject 
smoked mainly in the evenings, all the other subjects 
smoked consistently from morning to bedtime. The 
subjects were from different ethnic groups: 9 Caucasians, 
2 Mixed Ethnicity and 1 Oriental.  
 
 
Unstimulated vs. stimulated saliva samples  
 
Mean weight for saliva collected by unstimulated 
technique was 1.4 ± 0.7g (range 0.3 -3.3) and mean 
weight for saliva collected by stimulated technique was 
1.6 ± 0.7g (range 0.3 - 3.3). Subjects showed a signi-
ficant reduction in salivary nicotine levels when collected 
by stimulation technique (mean 1070.6 ± 728.5 ng/ml: 
range 367.3 - 2496.4) as compared to unstimulated 
technique (mean 2348.7 ± 1261.3 ng/ml: range 899.9 -
4611.5) (t 11 = 4.28, p=0.001). Salivary cotinine concen-
trations, however, showed an opposite change. Salivary 
cotinine collected by stimulated technique (387.9 ± 382.3 
ng/ml, range 28.4 -1449.7) was significantly higher than 
unstimulated technique (257.5 ± 275.8 ng/ml, range 9.6 -
1019.9) (t 11 = -2.95, p=0.013).  
Figure 1 illustrates the changes in salivary nicotine and 
salivary cotinine concentrations when collection by 
unstimulated and stimulated technique. The unstimulated 
sample collection method resulted in higher nicotine 
concentration but lower cotinine concentration than 
stimulated method.  
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Table 1. Nicotine and cotinine concentrations in unstimulated and stimulated saliva samples. 
 
Unstimulated Stimulated 
Subject Ethnic group No of 
cig/day BMI 
Type of 
cigarette 
smoked 
Nic 
(ng/ml) 
Cot 
(ng/ml) 
Nic (ng/ml) Cot 
(ng/ml) 
1 Caucasian 15 19.9 Filtered 4611.5 332.2 1722.8 338.4 
2 Caucasian 20 26.9 Filtered 3406.0 367.2 1431.4 691.3 
3 Mixed Ethnicity 10 39.7 Filtered 3414.8 1019.9 1431.4 1449.7 
4 Caucasian 13 26.5 Filtered 3865.6 399.1 2496.4 335.3 
5 Oriental 2 20.5 Filtered 1179.4 9.6 510.2 28.4 
6 Mixed Ethnicity 10 28.5 Filtered 1654.9 289.8 645.4 286.7 
7 Caucasian 15 22.3 Hand-rolled 1590.8 37.8 1280.0 175.8 
8 Caucasian 20 25.6 Hand-rolled 899.9 211.4 604.3 483.5 
9 Caucasian 13 26.3 Hand-rolled 3095.8 118.3 1001.9 193.8 
10 Caucasian 20 24.8 Hand-rolled 1001.9 189.5 1070.0 425.5 
11 Caucasian 16 25.5 Hand-rolled 1440.1 80.1 887.0 191.8 
12 Caucasian 20 22.3 Hand-rolled 2024.0 35.5 367.3 54.0 
  
Nic-nicotine, Cot-cotinine. 
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Figure 1. Salivary nicotine and cotinine concentration by unstimulated and stimulated technique. 
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DISCUSSION 
 
This study highlights the importance of standardising the 
salivary collection technique. Salivary nicotine concen-
tration showed a significant reduction when collected by 
stimulation as compared to unstimulated technique. In 
contrast, salivary cotinine concentration showed 
increased concentration when collected by stimulation 
technique.  
The findings in this study could be explained by how 
drugs such as nicotine and cotinine are absorbed across 
the lipophilic oral mucosa (Kidwell et al., 1998). This 
absorption process is by passive diffusion, which is 
dependent on the proportion of the drug present in the 
unionised or unchanged form in the oral cavity. In the 
unionised form, passive diffusion of a drug is faster than 
in the ionised form. This is because unionised or 
uncharged molecules have greater solubility in the lipo-
philic cellular membranes found in the oral mucosa. The 
proportion of the unionised form of a drug also depends 
on the dissociation constant of the compound and the pH 
of the biological medium. Therefore, the concentration of 
nicotine and cotinine in saliva will be dependent upon 
their existence in an unionised form which can be altered 
by manipulating the pH of the oral cavity (Kidwell et al., 
1998).  
In order to explain the effects that different stimulation 
techniques have on salivary concentration of drugs, an 
understanding of how stimulation affects salivary flow 
rates is needed. Salivary flow rates vary significantly both 
between individuals and under different conditions (Liu 
and Delgado, 1999). Salivary flow rates affect pH of 
saliva (Kidwell et al 1998; Schneider et al 1997) and 
saliva collected by stimulation (e.g. chewing) produces 
higher salivary flow rates, generates carbon monoxide, 
and a higher bicarbonate concentration  which  causes  a  
higher pH value. It was reported that pH of saliva 
increases with stimulation. For example, the pH of 
unstimulated saliva range between 5.6 - 7.0, but with 
stimulation it could increase up to 8.0 (Ciolino et al., 
2001b).  It was also reported that an increase of salivary 
flow rates from 0.55 ml/min to 0.88 ml/min changed sali-
vary pH from 7.12 to 7.17 (Polland et al., 2003). Dawes 
(1969, 2005) showed that the bicarbonate concentration 
of saliva increased with flow rates. At salivary flow rates 
of 0.5 ml/min, salivary pH was 7.3 and at salivary flow 
rates of 1.0 ml/min, salivary pH increased to 7.5 (Dawes, 
1969; Dawes, 2005b). This alkaline environment 
facilitates reabsorption of drugs with high pKa, producing 
lower salivary drug concentrations, but reduces the 
reabsorption of drugs with low pKa, producing higher 
salivary concentrations. Therefore, nicotine with pKa of 
8.0 will be in unionised form at alkalinised salivary pH, 
hence facilitating reabsorption into buccal mucosa, and 
causing reduced nicotine concentration in saliva (Kidwell 
et al., 1998; Zevin et al., 1998; Zevin et al., 2000). How-
ever, cotinine with pKa < 5.0 (Beckett et al., 1972), will be 
present in a more ionised form at alkalinised salivary  pH,  
 
 
 
 
hence resulting in less reabsorption across buccal muco-
sa, and an increase in salivary cotinine concentration. 
In this study, salivary nicotine collected by unstimulated 
technique showed a wide range of concentrations. This 
could be due to inter-individual variability of nicotine 
intake when smoking a cigarette. It could also reflect the 
wide range of tobacco consumption as the number of 
cigarettes smoked ranged from 2 to 20 cig/day or could 
be possibly due to contamination from recent smoking. 
However, this could not be attributed to the effect of 
passive smoking as the reported mean salivary nicotine 
concentration from passive smoking was 4.8 ng/ml and 
mean   salivary   nicotine   concentration   from   cigarette 
smoking was 672.5 ng/ml (Jarvis, 1984). Thus passive 
smoking could not be responsible for this wide 
interindividual variability of salivary nicotine collected by 
unstimulated technique. The pH of saliva was also not 
measured in this study. However, other factors which 
could affect the pH of saliva and the concentration of 
nicotine and cotinine in saliva such as time of day and 
duration of collection of saliva were standardised.  The 
subjects were also asked to rinse their mouth prior to the 
procedure to eliminate trace of nicotine in the oral cavity 
from a prior cigarette. 
The findings of this study suggest that collection using 
unstimulated methods produced the highest salivary 
nicotine concentration, whereas collection by stimulation 
technique produced the highest salivary cotinine concen-
trations. This is most likely due to the different influence 
the different techniques has on salivary pH. Therefore, in 
research and clinical practice, it is important to 
standardise salivary collection techniques, taking into 
account that different collection techniques may produce 
contrasting results. When contemplating which technique 
to be used, investigators need to consider a technique 
which would serve their purpose best. Thus unstimulated 
technique is recommended for salivary nicotine 
estimation and stimulated technique is recommended for 
salivary cotinine estimation. 
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